Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NSRX
#4733
Nasus Pharma Ltd.
2.250
0
USD
+2.26%
Sector:
Unknown
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.26%
Monthly Change
-23.47%
6 month change
-70.67%
Year Change
-72.12%
Previous Close
2.200
2
Open
2.250
0
Bid
Ask
Low
2.250
0
High
2.270
0
Volume
3
Markets
US Stock Market
NSRX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 25
TTM
Key stats
Total common shares outstanding
9.02 M
—
Valuation ratios
Enterprise value
81.37 M
—
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
26.48
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
2.24
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
0.02
—
Debt to equity ratio
0.04
—
Long term debt to total assets ratio
0
—
Long term debt to total equity ratio
0
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
0.01
—
Cash per share
0.15
—
Net current asset value per share
0.61
—
Tangible book value per share
0.35
—
Working capital per share
0.34
—
Book value per share
0.35
—